IL1B and ulcerative colitis: Recent studies have shown that casticin has a strong inhibitory effect on inflammation in DSS‐induced ulcerative colitis, lipopolysaccharide‐induced acute lung injury, and IL‐1‐induced human osteoarthritis.13, 35, 36